Trial intelligence / Profile preview

Study of Maintenance of the Efficiency and Adverse Effects of Pharmacological Treatments in Sex Offenders With Paraphilia

NCT04316650Withdrawn

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jun 2023
Primary completion
Dec 2026
Countries
1
01

Overview

Open-label trial in paraphilic disorder (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Sexual desire and activity intensity scale at 36 months and Incidence of adverse events at 36 months. Planned start Jun 2023; status: withdrawn.

02

Conditions

paraphilic disorder

Beyond the preview

Go deeper on NCT04316650.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04316650.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call